Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Heat Biologics nets $24.2mm in IPO

Executive Summary

Heat Biologics Inc. (cancer and infectious disease immunotherapies) has netted $24.2mm in its initial public offering of 2.6mm shares (including partial exercise of the overallotment)--slightly more than the 2.3mm planned--for $10, the bottom end of its $10-12 range.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies